首页> 美国卫生研究院文献>Antimicrobial Resistance and Infection Control >Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea
【2h】

Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea

机译:在韩国共同生产质粒介导的AmpCβ-内酰胺酶DHA-1和广谱β-内酰胺酶的血清型K1肺炎克雷伯菌ST23菌株的出现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSerotype K1 Klebsiella pneumoniae has emerged as an important community pathogen causing various infections, including liver abscesses. Although serotype K1 K. pneumoniae community isolates have been reported as susceptible to most classes of antimicrobial agents, a few cases of infection caused by extended-spectrum beta-lactamase (ESBL)-producing serotype K1 K. pneumoniae have recently been reported in Asian countries. We identified three ESBL-producing strains of serotype K1 K. pneumoniae and conducted a molecular characterization of their drug resistance.
机译:背景血清型K1肺炎克雷伯菌已作为重要的社区病原体出现,引起各种感染,包括肝脓肿。尽管据报道血清型K1肺炎克雷伯菌社区分离株对大多数种类的抗菌剂敏感,但最近在亚洲国家中报告了一些由广谱β-内酰胺酶(ESBL)产生的血清型K1肺炎克雷伯菌引起的感染病例。 。我们确定了血清型K1肺炎克雷伯菌的三种ESBL产生菌株,并对其耐药性进行了分子表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号